Clinical trial

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy…

NCT00489554 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00489554
Title Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age
Official title Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Infanrix Hexa and Rotarix
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Infections, Streptococcal, Streptococcus Pneumoniae Vaccines
Intervention type Biological
Interventions Synflorix, Infanrix hexa, Rotarix
Enrollment 230
Start date Jul 3, 2007
Primary completion Mar 31, 2008
Completion Mar 31, 2008
First posted Jun 21, 2007
Last update posted Jan 13, 2020
Countries Mexico

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies